Search results
Macy’s (NYSE:M) Releases Q2 2024 Earnings Guidance
ETF DAILY NEWS· 11 hours agoMacy’s (NYSE:M – Get Free Report) updated its second quarter 2024 earnings guidance on Thursday. The company provided EPS guidance of 0.250-0.330 for the period, compared to the consensus EPS ...
Israel must halt offensive in Rafah, UN's top court rules. Israel is unlikely to comply.
USA TODAY via Yahoo News· 1 day ago"Where is President Biden’s 'red line'?" Several of the U.S.’s European allies, including Ireland,...
BI Asset Management Fondsmaeglerselskab A S Has $469,000 Stake in Textron Inc. (NYSE:TXT)
ETF DAILY NEWS· 2 days agoThe fund owned 5,829 shares of the aerospace company’s stock after acquiring an additional 2,091...
Crime, Corruption Keep South Africa’s S&P Rating in Check
Bloomberg· 2 days agoS&P Global Ratings said it’s closely monitoring the outcome of South Africa’s elections next week...
BI Asset Management Fondsmaeglerselskab A S Decreases Stake in Xcel Energy Inc. (NASDAQ:XEL)
ETF DAILY NEWS· 1 day agoThe institutional investor owned 10,373 shares of the company’s stock after selling 12,406 shares...
This High-Tech Tent Can Prevent EMP Attacks From Crippling Cybertrucks
Forbes· 15 hours agoIn response, a company based in Santa Barbara, California called Mission Darkness recently unveiled...
Britain to World: Don’t Let What Happened to Us Happen to You
The Wall Street Journal· 1 day agoPresident Biden, fighting for re-election with abysmal approval ratings, can count himself lucky in...
Stocks Rise on Hopes Inflation Pressures Will Ease: Markets Wrap
Bloomberg via Yahoo Finance· 24 hours ago(Bloomberg) -- Stocks rose after data showed American consumers tempered inflation expectations,...
Tetra Tech, Inc. (NASDAQ:TTEK) Shares Bought by BI Asset Management Fondsmaeglerselskab A S
ETF DAILY NEWS· 11 hours agoBI Asset Management Fondsmaeglerselskab A S grew its holdings in shares of Tetra Tech, Inc....
Novo’s Ozempic Slashes Risk of Death in Kidney Disease Study
Bloomberg· 1 day agoHave a confidential tip for our reporters? Novo Nordisk A/S’s blockbuster diabetes drug Ozempic cut...